Business context and reporting period
Important filing-identity discrepancy: The request identifies TERAWULF INC., but the supplied Form 10-Q is for IKONICS Corporation (Minnesota), for the unaudited quarter ended September 30, 2017. The filing describes businesses in imaging and printing materials, digital texturing, and advanced materials for aerospace and related industries. This summary reflects the supplied filing, not TeraWulf.
Financial performance
| Metric | Three months ended September 30 | Nine months ended September 30 |
|---|---|---|
| Net sales | 2017: $3.984 million; 2016: $4.608 million | 2017: $12.298 million; 2016: $12.817 million |
| Gross profit / margin | 2017: $1.324 million / 33.2%; 2016: $1.667 million / 36.2% | 2017: $3.857 million / 31.4%; 2016: $4.486 million / 35.0% |
| Operating income (loss) | 2017: $(150,190); 2016: $159,693 | 2017: $(871,422); 2016: $(110,697) |
| Net income (loss) | 2017: $(110,953); 2016: $82,266 | 2017: $(594,916); 2016: $(71,321) |
| Operating cash flow | Not presented separately for the quarter | 2017: $147,620; 2016: $804,185 |
For the nine-month period, SG&A was $4.210 million (up from $4.122 million) and R&D was $519,160 (up from $475,165). Interest expense was $62,475, versus $36,720. Basic and diluted loss per share were both $0.30 for the nine months, compared with $0.04 in the prior-year period.
Liquidity, debt and cash flow
At September 30, 2017, cash and cash equivalents were $2.001 million and short-term investments were $1.915 million, for combined cash and short-term investments of $3.916 million. Current assets were $8.539 million and current liabilities $1.282 million. Total debt, net, was approximately $3.110 million, including $130,000 current and $2.980 million long-term; the company also had a $2.05 million undrawn bank line of credit expiring September 30, 2019. The company said it complied with the quarterly debt-service coverage requirement at September 30.
Nine-month cash increased $953,000 to $2.001 million. Investing activities provided $1.141 million, largely reflecting net certificate-of-deposit activity; financing activities used $336,000, including $234,000 for share repurchases and $104,000 in debt principal payments. Inventories rose $560,000, which management attributed to building stock for fourth-quarter sales.
Changes versus prior comparable periods
- Third-quarter sales fell 13.5%; management cited softer domestic demand, timing of Asian export sales, lower high-margin Imaging film sales, and lower DTX sales. AMS sales were also lower year over year.
- For the first nine months, sales declined 4.0%. Domestic and Imaging sales fell; AMS sales were down 34.0% amid a major customer’s temporary inventory overstocking. DTX sales increased 131.1%, partly from two printer sales, and Export sales rose 1.2%.
- Gross margin contracted in both comparison periods. Management attributed this to lower volume and less favorable product mix, including a higher share of lower-margin Export sales and lower shares of higher-margin Imaging sales; two low-margin DTX printer sales also weighed on the nine-month margin.
- Operating cash flow declined to $148,000 from $804,000 for the nine-month period, while cash balances increased, in part due to investment maturities and working-capital movements.
Outlook, commentary and risks
- Management said AMS orders returned to expected levels in the third quarter after a temporary customer-related slowdown and expected that pattern to continue for the rest of 2017; it cited two long-term aerospace sales agreements and negotiations on a third.
- Management expected some Imaging sales shortfall to be recovered in the fourth quarter. It also reported an October launch of SubTHAT! and a $258,000 fourth-quarter purchase order. These are management statements, not guaranteed results.
- The company expected approximately $75,000 of additional 2017 capital expenditures, mainly for production and process improvements, funded from existing cash and operating cash flow.
- Key cited business risks include soft market conditions, competitive pressure, reliance on a major AMS customer, product mix and sales timing, and a strong U.S. dollar making international sales more challenging. Forward-looking statements are subject to risks described in the company’s 2016 Form 10-K and subsequent filings.
- The filing reports no legal proceedings, no off-balance-sheet arrangements, and no material change in internal control over financial reporting. It states disclosure controls were effective. The company had repurchased 25,000 shares in August under a new 100,000-share authorization.
- The company was evaluating new revenue-recognition guidance expected to be adopted in the first quarter of 2018 and had not selected its transition method. It adopted stock-compensation guidance in 2017 with minimal financial-statement impact.
Important facts for investors to verify
- Confirm the intended issuer: the provided filing is IKONICS Corporation’s 2017 third-quarter 10-Q, not a TeraWulf filing.
- Review subsequent filings for whether AMS customer orders, the expected fourth-quarter sales recovery, and the SubTHAT! purchase order translated into revenue and cash flow.
- Assess whether falling gross margins and weak operating results improved, and whether inventory growth converted to sales without obsolescence or further cash-flow pressure.
- Check debt-service covenant compliance, debt repayment, and liquidity after the reporting date; the filing’s liquidity assessment is management’s view as of the filing period.